CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal Disease - Concepedia

Concepedia

Publication | Open Access

CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal Disease

DOI Full Paper Access

110

Citations

31

References

2009

Year

Bruce L. Riser, Feridoon Najmabadi, Bernard Perbal, Darryl R. Peterson, Jo Ann Rambow, M Riser, Ernest Sukowski, Herman Yeger, Sarah C. Riser

American Journal Of Pathology

InflammationFibrosisUrologyNegative RegulatorRenal FunctionMedicineNovel Endogenous InhibitorRenal InflammationPathologyFibrotic PathwayVascular BiologyRenal PathophysiologyKidney Tubule RemodelingChronic Kidney DiseaseCell BiologyCell SignalingNephrologyKidney Research

References

	Year	Citations

Page 1

Page 1